A non-invasive preoperative prediction model for predicting axillary lymph node metastasis in breast cancer based on a machine learning approach: combining ultrasonographic parameters and breast gamma specific imaging features
- PMID: 38802938
- PMCID: PMC11131273
- DOI: 10.1186/s13014-024-02453-2
A non-invasive preoperative prediction model for predicting axillary lymph node metastasis in breast cancer based on a machine learning approach: combining ultrasonographic parameters and breast gamma specific imaging features
Abstract
Background: The most common route of breast cancer metastasis is through the mammary lymphatic network. An accurate assessment of the axillary lymph node (ALN) burden before surgery can avoid unnecessary axillary surgery, consequently preventing surgical complications. In this study, we aimed to develop a non-invasive prediction model incorporating breast specific gamma image (BSGI) features and ultrasonographic parameters to assess axillary lymph node status.
Materials and methods: Cohorts of breast cancer patients who underwent surgery between 2012 and 2021 were created (The training set included 1104 ultrasound images and 940 BSGI images from 235 patients, the test set included 568 ultrasound images and 296 BSGI images from 99 patients) for the development of the prediction model. six machine learning (ML) methods and recursive feature elimination were trained in the training set to create a strong prediction model. Based on the best-performing model, we created an online calculator that can make a linear predictor in patients easily accessible to clinicians. The receiver operating characteristic (ROC) and calibration curve are used to verify the model performance respectively and evaluate the clinical effectiveness of the model.
Results: Six ultrasonographic parameters (transverse diameter of tumour, longitudinal diameter of tumour, lymphatic echogenicity, transverse diameter of lymph nodes, longitudinal diameter of lymph nodes, lymphatic color Doppler flow imaging grade) and one BSGI features (axillary mass status) were selected based on the best-performing model. In the test set, the support vector machines' model showed the best predictive ability (AUC = 0.794, sensitivity = 0.641, specificity = 0.8, PPV = 0.676, NPV = 0.774 and accuracy = 0.737). An online calculator was established for clinicians to predict patients' risk of ALN metastasis ( https://wuqian.shinyapps.io/shinybsgi/ ). The result in ROC showed the model could benefit from incorporating BSGI feature.
Conclusion: This study developed a non-invasive prediction model that incorporates variables using ML method and serves to clinically predict ALN metastasis and help in selection of the appropriate treatment option.
Keywords: Axillary lymph node; Breast neoplasms; Breast specific gamma image; Machine learning; Ultrasonography.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures






Similar articles
-
Machine Learning Model for Predicting Axillary Lymph Node Metastasis in Clinically Node Positive Breast Cancer Based on Peritumoral Ultrasound Radiomics and SHAP Feature Analysis.J Ultrasound Med. 2024 Sep;43(9):1611-1625. doi: 10.1002/jum.16483. Epub 2024 May 29. J Ultrasound Med. 2024. PMID: 38808580
-
Enhancing Specificity in Predicting Axillary Lymph Node Metastasis in Breast Cancer through an Interpretable Machine Learning Model with CEM and Ultrasound Integration.Technol Cancer Res Treat. 2025 Jan-Dec;24:15330338251334735. doi: 10.1177/15330338251334735. Epub 2025 Apr 17. Technol Cancer Res Treat. 2025. PMID: 40241520 Free PMC article.
-
Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in invasive breast cancer: A machine learning, multicenter study.EBioMedicine. 2021 Jul;69:103460. doi: 10.1016/j.ebiom.2021.103460. Epub 2021 Jul 4. EBioMedicine. 2021. PMID: 34233259 Free PMC article. Clinical Trial.
-
Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.J Surg Oncol. 2004 Mar;85(3):102-11. doi: 10.1002/jso.20022. J Surg Oncol. 2004. PMID: 14991881 Review.
-
Deep learning-based breast MRI for predicting axillary lymph node metastasis: a systematic review and meta-analysis.Cancer Imaging. 2025 Mar 31;25(1):44. doi: 10.1186/s40644-025-00863-3. Cancer Imaging. 2025. PMID: 40165212 Free PMC article.
Cited by
-
Prognosticating axillary lymph node metastasis in breast cancer through integrated photoacoustic imaging, ultrasound, and clinical parameters.Breast Cancer Res. 2025 Jul 1;27(1):123. doi: 10.1186/s13058-025-02073-y. Breast Cancer Res. 2025. PMID: 40598374 Free PMC article.
References
-
- Sung H, Ferlay J, Siegel RL, Global Cancer S. 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians. (2021);71(3):209–49. 10.3322/caac.21660 - PubMed
-
- Krag DN, Anderson SJ, Julian TB. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. LANCET ONCOL. 2010;11(10):927–33. doi: 10.1016/S1470-2045(10)70207-2. - DOI - PMC - PubMed
-
- Donker M, van Tienhoven G, Straver ME. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981–22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. LANCET ONCOL. 2014;15(12):1303–10. doi: 10.1016/S1470-2045(14)70460-7. - DOI - PMC - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical